Skip to content

Moody Aldrich Partners LLC: REVG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Moody Aldrich Partners LLC on REVG, newest first. How the timeline and the estimate are built.

Moody Aldrich Partners LLC held 0 REVG shares at 2026-03-31 per its 13F-HR filed 2026-04-20.

the latest 13F is the newest step

  1. period ended2026-03-31
    13F 0 shares
    Change vs previous 13F -82,804 shares

    13F-HR 0000936941-26-000003 filed by Moody Aldrich Partners LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-12-31
    13F 82,804 shares
    Change vs previous 13F -4,000 shares

    0.94% of the 13F portfolio, value $5,035,311.

    13F-HR 0000936941-26-000002 filed by Moody Aldrich Partners LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-09-30
    13F 86,804 shares
    Change vs previous 13F -43,046 shares

    0.93% of the 13F portfolio, value $4,919,183.

    13F-HR 0000936941-25-000013 filed by Moody Aldrich Partners LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-06-30
    13F 129,850 shares
    Change vs previous 13F +63,375 shares

    1.2% of the 13F portfolio, value $6,179,562.

    13F-HR 0001085146-25-004478 filed by Moody Aldrich Partners LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-03-31
    13F 66,475 shares
    Change vs previous 13F not available

    0.44% of the 13F portfolio, value $2,100,610.

    13F-HR 0001085146-25-002404 filed by Moody Aldrich Partners LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).